Works by Hirooka, Masashi

Results: 175

Efficacy of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma in immunotherapy era clinical practice.
Published in:
Hepatology Research, 2025, v. 55, n. 3, p. 444, doi. 10.1111/hepr.14136
By:
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ohama, Hideko;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Kawata, Kazuhito;
- Naganuma, Atsushi
Publication type:
Article
The association between renal elasticity evaluated by Real-time tissue elastography and renal fibrosis.
Published in:
Clinical & Experimental Nephrology, 2021, v. 25, n. 9, p. 981, doi. 10.1007/s10157-021-02063-2
By:
- Makita, Ayu;
- Nagao, Tomoaki;
- Miyoshi, Ken-ichi;
- Koizumi, Yohei;
- Kurata, Mie;
- Kondo, Fumikazu;
- Shichijo, Satoru;
- Hirooka, Masashi;
- Yamaguchi, Osamu
Publication type:
Article
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
Published in:
Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2042
By:
- Ohama, Hideko;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Hatanaka, Takeshi;
- Tani, Joji;
- Takaguchi, Koichi;
- Atsukawa, Masanori;
- Itobayashi, Ei;
- Nishimura, Takashi;
- Tsuji, Kunihiko;
- Tajiri, Kazuto;
- Ishikawa, Toru;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Fukunishi, Shinya;
- Ogawa, Chikara;
- Kakizaki, Satoru;
- Shimada, Noritomo
Publication type:
Article
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience.
Published in:
Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1464
By:
- Atsushi Hiraoka;
- Takashi Kumada;
- Toshifumi Tada;
- Masashi Hirooka;
- Kazuya Kariyama;
- Joji Tani;
- Masanori Atsukawa;
- Koichi Takaguchi;
- Ei Itobayashi;
- Shinya Fukunishi;
- Kunihiko Tsuji;
- Toru Ishikawa;
- Kazuto Tajiri;
- Hironori Ochi;
- Satoshi Yasuda;
- Hidenori Toyoda;
- Chikara Ogawa;
- Takashi Nishimura;
- Takeshi Hatanaka;
- Hideko Ohama
Publication type:
Article
Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib.
Published in:
Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-78539-4
By:
- Ohama, Hideko;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
PKR associates with 4.1R to promote anchorage-independent growth of hepatocellular carcinoma and lead to poor prognosis.
Published in:
Scientific Reports, 2024, v. 12, n. 1, p. 1, doi. 10.1038/s41598-024-75142-5
By:
- Okujima, Yusuke;
- Watanabe, Takao;
- Ito, Takeshi;
- Inoue, Yasumichi;
- Kasai, Yutaka;
- Imai, Yusuke;
- Nakamura, Yoshiko;
- Koizumi, Mitsuhito;
- Yoshida, Osamu;
- Tokumoto, Yoshio;
- Hirooka, Masashi;
- Abe, Masanori;
- Kawakami, Ryosuke;
- Saitou, Takashi;
- Imamura, Takeshi;
- Murakami, Yoshinori;
- Hiasa, Yoichi
Publication type:
Article
PKR associates with 4.1R to promote anchorage-independent growth of hepatocellular carcinoma and lead to poor prognosis.
Published in:
Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-75142-5
By:
- Okujima, Yusuke;
- Watanabe, Takao;
- Ito, Takeshi;
- Inoue, Yasumichi;
- Kasai, Yutaka;
- Imai, Yusuke;
- Nakamura, Yoshiko;
- Koizumi, Mitsuhito;
- Yoshida, Osamu;
- Tokumoto, Yoshio;
- Hirooka, Masashi;
- Abe, Masanori;
- Kawakami, Ryosuke;
- Saitou, Takashi;
- Imamura, Takeshi;
- Murakami, Yoshinori;
- Hiasa, Yoichi
Publication type:
Article
Combined evaluation of Fibrosis‐4 index and fatty liver for stratifying the risk for diabetes mellitus.
Published in:
Journal of Diabetes Investigation, 2022, v. 13, n. 9, p. 1577, doi. 10.1111/jdi.13812
By:
- Todo, Yasuhiko;
- Miyake, Teruki;
- Furukawa, Shinya;
- Matsuura, Bunzo;
- Ishihara, Toru;
- Miyazaki, Masumi;
- Shiomi, Akihito;
- Nakaguchi, Hironobu;
- Kanzaki, Sayaka;
- Yamamoto, Yasunori;
- Koizumi, Yohei;
- Yoshida, Osamu;
- Tokumoto, Yoshio;
- Hirooka, Masashi;
- Takeshita, Eiji;
- Kumagi, Teru;
- Ikeda, Yoshio;
- Abe, Masanori;
- Iwata, Takeru;
- Hiasa, Yoichi
Publication type:
Article
Fatty liver with metabolic disorder, such as metabolic dysfunction‐associated fatty liver disease, indicates high risk for developing diabetes mellitus.
Published in:
Journal of Diabetes Investigation, 2022, v. 13, n. 7, p. 1245, doi. 10.1111/jdi.13772
By:
- Miyake, Teruki;
- Matsuura, Bunzo;
- Furukawa, Shinya;
- Ishihara, Toru;
- Yoshida, Osamu;
- Miyazaki, Masumi;
- Watanebe, Kyoko;
- Shiomi, Akihito;
- Nakaguchi, Hironobu;
- Yamamoto, Yasunori;
- Koizumi, Yohei;
- Tokumoto, Yoshio;
- Hirooka, Masashi;
- Takeshita, Eiji;
- Kumagi, Teru;
- Abe, Masanori;
- Ikeda, Yoshio;
- Iwata, Takeru;
- Hiasa, Yoichi
Publication type:
Article
Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status.
Published in:
Journal of Diabetes Investigation, 2021, v. 12, n. 10, p. 1890, doi. 10.1111/jdi.13548
By:
- Miyake, Teruki;
- Matsuura, Bunzo;
- Furukawa, Shinya;
- Yoshida, Osamu;
- Hirooka, Masashi;
- Kumagi, Teru;
- Ishihara, Toru;
- Kanzaki, Sayaka;
- Nakaguchi, Hironobu;
- Miyazaki, Masumi;
- Nakamura, Yoshiko;
- Yamamoto, Yasunori;
- Koizumi, Yohei;
- Tokumoto, Yoshio;
- Takeshita, Eiji;
- Ikeda, Yoshio;
- Abe, Masanori;
- Kitai, Kohichiro;
- Hiasa, Yoichi
Publication type:
Article
Relationship between urine pH and abnormal glucose tolerance in a community‐based study.
Published in:
Journal of Diabetes Investigation, 2018, v. 9, n. 4, p. 769, doi. 10.1111/jdi.12777
By:
- Yoshida, Sakiko;
- Miyake, Teruki;
- Yamamoto, Shin;
- Furukawa, Shinya;
- Niiya, Tetsuji;
- Senba, Hidenori;
- Kanzaki, Sayaka;
- Yoshida, Osamu;
- Ishihara, Toru;
- Koizumi, Mitsuhito;
- Hirooka, Masashi;
- Kumagi, Teru;
- Abe, Masanori;
- Kitai, Kohichiro;
- Matsuura, Bunzo;
- Hiasa, Yoichi
Publication type:
Article
Clinical and Pathological Features of Immune Checkpoint Inhibitor-induced Liver Injury in Comparison with Drug-induced Liver Injury and Autoimmune Hepatitis.
Published in:
Journal of Gastrointestinal & Liver Diseases, 2023, v. 32, n. 4, p. 488, doi. 10.15403/jgld-5045
By:
- Kotaro Sunago;
- Masanori Abe;
- Osamu Yoshida;
- Takao Watanabe;
- Yoshiko Nakamura;
- Yusuke Imai;
- Yohei Koizumi;
- Masashi Hirooka;
- Yoshio Tokumoto;
- Yoichi Hiasa
Publication type:
Article
Risk of hypervascularization in small hypovascular hepatic nodules showing hypointense in the hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with chronic liver disease.
Published in:
2012
By:
- Takechi M;
- Tsuda T;
- Yoshioka S;
- Murata S;
- Tanaka H;
- Hirooka M;
- Mochizuki T;
- Takechi, Megumi;
- Tsuda, Takaharu;
- Yoshioka, Shinji;
- Murata, Shigetoshi;
- Tanaka, Hiroaki;
- Hirooka, Masashi;
- Mochizuki, Teruhito
Publication type:
journal article
New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode.
Published in:
PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0221548
By:
- Koizumi, Yohei;
- Hirooka, Masashi;
- Tamaki, Nobuharu;
- Yada, Norihisa;
- Nakashima, Osamu;
- Izumi, Namiki;
- Kudo, Masatoshi;
- Hiasa, Yoichi
Publication type:
Article
Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation.
Published in:
PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0212589
By:
- Imai, Yusuke;
- Yoshida, Osamu;
- Watanabe, Takao;
- Yukimoto, Atsushi;
- Koizumi, Yohei;
- Ikeda, Yoshio;
- Tokumoto, Yoshio;
- Hirooka, Masashi;
- Abe, Masanori;
- Hiasa, Yoichi
Publication type:
Article
High Serum Palmitic Acid is Associated with Low Antiviral Effects of Interferon-Based Therapy for Hepatitis C Virus.
Published in:
Lipids, 2012, v. 47, n. 11, p. 1053, doi. 10.1007/s11745-012-3716-8
By:
- Miyake, Teruki;
- Hiasa, Yoichi;
- Hirooka, Masashi;
- Tokumoto, Yoshio;
- Watanabe, Takao;
- Furukawa, Shinya;
- Ueda, Teruhisa;
- Yamamoto, Shin;
- Kumagi, Teru;
- Miyaoka, Hiroaki;
- Abe, Masanori;
- Matsuura, Bunzo;
- Onji, Morikazu
Publication type:
Article
Relationship between body composition and the histology of non-alcoholic fatty liver disease: a cross-sectional study.
Published in:
2021
By:
- Miyake, Teruki;
- Miyazaki, Masumi;
- Yoshida, Osamu;
- Kanzaki, Sayaka;
- Nakaguchi, Hironobu;
- Nakamura, Yoshiko;
- Watanabe, Takao;
- Yamamoto, Yasunori;
- Koizumi, Yohei;
- Tokumoto, Yoshio;
- Hirooka, Masashi;
- Furukawa, Shinya;
- Takeshita, Eiji;
- Kumagi, Teru;
- Ikeda, Yoshio;
- Abe, Masanori;
- Toshimitsu, Kumiko;
- Matsuura, Bunzo;
- Hiasa, Yoichi
Publication type:
journal article
Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis.
Published in:
Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102540
By:
- Miyake, Teruki;
- Furukawa, Shinya;
- Matsuura, Bunzo;
- Yoshida, Osamu;
- Miyazaki, Masumi;
- Shiomi, Akihito;
- Kanzaki, Sayaka;
- Nakaguchi, Hironobu;
- Sunago, Kotaro;
- Nakamura, Yoshiko;
- Imai, Yusuke;
- Watanabe, Takao;
- Yamamoto, Yasunori;
- Koizumi, Yohei;
- Tokumoto, Yoshio;
- Hirooka, Masashi;
- Kumagi, Teru;
- Abe, Masanori;
- Hiasa, Yoichi
Publication type:
Article
Therapeutic effects of the PKR inhibitor C16 suppressing tumor proliferation and angiogenesis in hepatocellular carcinoma in vitro and in vivo.
Published in:
Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-61579-x
By:
- Watanabe, Takao;
- Ninomiya, Hiroko;
- Saitou, Takashi;
- Takanezawa, Sota;
- Yamamoto, Shin;
- Imai, Yusuke;
- Yoshida, Osamu;
- Kawakami, Ryosuke;
- Hirooka, Masashi;
- Abe, Masanori;
- Imamura, Takeshi;
- Hiasa, Yoichi
Publication type:
Article
Using ALBI score at the start of sorafenib treatment to predict regorafenib treatment candidates in patients with hepatocellular carcinoma.
Published in:
Japanese Journal of Clinical Oncology, 2019, v. 49, n. 1, p. 42, doi. 10.1093/jjco/hyy153
By:
- Yukimoto, Atsushi;
- Hirooka, Masashi;
- Hiraoka, Atsushi;
- Michitaka, Kojiro;
- Ochi, Hironori;
- Joko, Kouji;
- Imai, Yusuke;
- Watanabe, Takao;
- Koizumi, Yohei;
- Yoshida, Osamu;
- Abe, Masanori;
- Hiasa, Yoichi
Publication type:
Article
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.
Published in:
Digestive Diseases, 2017, v. 35, n. 6, p. 602, doi. 10.1159/000480256
By:
- Atsushi Hiraoka;
- Takashi Kumada;
- Masatoshi Kudo;
- Masashi Hirooka;
- Yohei Koizumi;
- Yoichi Hiasa;
- Kazuto Tajiri;
- Hidenori Toyoda;
- Toshifumi Tada;
- Hironori Ochi;
- Koji Joko;
- Noritomo Shimada;
- Akihiro Deguchi;
- Toru Ishikawa;
- Michitaka Imai;
- Kunihiko Tsuji;
- Kojiro Michitaka
Publication type:
Article
Abdominal Ultrasound Findings of Tumor-Forming Hepatic Malignant Lymphoma.
Published in:
Digestive Diseases, 2017, v. 35, n. 6, p. 498, doi. 10.1159/000480138
By:
- Shogo Kitahata;
- Atsushi Hiraoka;
- Masatoshi Kudo;
- Taisei Murakami;
- Marie Ochi;
- Hirofumi Izumoto;
- Hidetaro Ueki;
- Miho Kaneto;
- Toshihiko Aibiki;
- Tomonari Okudaira;
- Hiroka Yamago;
- Yuji Miyamoto;
- Ryuichiro Iwasaki;
- Hideomi Tomida;
- Kenichiro Mori;
- Masato Kishida;
- Hideki Miyata;
- Eiji Tsubouchi;
- Masashi Hirooka;
- Yohei Koizumi
Publication type:
Article
Diagnosis of Fibrosis and Activity by a Combined Use of Strain and Shear Wave Imaging in Patients with Liver Disease.
Published in:
Digestive Diseases, 2017, v. 35, n. 6, p. 515, doi. 10.1159/000480140
By:
- Norihisa Yada;
- Nobuhura Tamaki;
- Yohei Koizumi;
- Masashi Hirooka;
- Osamu Nakashima;
- Yoichi Hiasa;
- Namiki Izumi;
- Masatoshi Kudo
Publication type:
Article
Hypovascular Hepatic Nodules Showing Hypointense on the Hepatobiliary-Phase Image of Gd-EOB-DTPA-Enhanced MRI to Develop a Hypervascular Hepatocellular Carcinoma: A Nationwide Retrospective Study on Their Natural Course and Risk Factors.
Published in:
Digestive Diseases, 2013, v. 31, n. 5/6, p. 472, doi. 10.1159/000355248
By:
- Inoue, Tatsuo;
- Hyodo, Tomoko;
- Murakami, Takamichi;
- Takayama, Yukihisa;
- Nishie, akihiro;
- Higaki, atsushi;
- Korenaga, Keiko;
- Sakamoto, azusa;
- Osaki, Yukio;
- aikata, Hiroshi;
- Chayama, Kazuaki;
- Suda, Takeshi;
- Takano, Toru;
- Miyoshi, Kennichi;
- Koda, Masahiko;
- Numata, Kazushi;
- Tanaka, Hironori;
- Iijima, Hiroko;
- Ochi, Hironori;
- Hirooka, Masashi
Publication type:
Article
Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach.
Published in:
Cancer Medicine, 2023, v. 12, n. 24, p. 21680, doi. 10.1002/cam4.6726
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Yokohama, Keisuke;
- Nishikawa, Hiroki
Publication type:
Article
Effect of butyrate‐producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab.
Published in:
Cancer Medicine, 2023, v. 12, n. 17, p. 17849, doi. 10.1002/cam4.6416
By:
- Nouso, Kazuhiro;
- Shiota, Shohei;
- Fujita, Rio;
- Wakuta, Akiko;
- Kariyama, Kazuya;
- Hiraoka, Atsushi;
- Atsukawa, Masanori;
- Tani, Joji;
- Tada, Toshifumi;
- Nakamura, Shinichiro;
- Tajiri, Kazuto;
- Kaibori, Masaki;
- Hirooka, Masashi;
- Itobayashi, Ei;
- Kakizaki, Satoru;
- Naganuma, Atsushi;
- Ishikawa, Toru;
- Hatanaka, Takeshi;
- Fukunishi, Shinya;
- Tsuji, Kunihiko
Publication type:
Article
Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Published in:
Cancer Medicine, 2023, v. 12, n. 7, p. 7772, doi. 10.1002/cam4.5535
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study.
Published in:
Cancer Medicine, 2023, v. 12, n. 6, p. 6980, doi. 10.1002/cam4.5495
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Kariyama, Kazuya;
- Tani, Joji;
- Hirooka, Masashi;
- Takaguchi, Koichi;
- Atsukawa, Masanori;
- Fukunishi, Shinya;
- Itobayashi, Ei;
- Tsuji, Kunihiko;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Ishikawa, Toru;
- Yasuda, Satoshi;
- Ogawa, Chikara;
- Toyoda, Hidenori;
- Hatanaka, Takeshi;
- Nishimura, Takashi;
- Kakizaki, Satoru
Publication type:
Article
Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study.
Published in:
Cancer Medicine, 2023, v. 12, n. 5, p. 5293, doi. 10.1002/cam4.5337
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Shimada, Noritomo
Publication type:
Article
The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC‐GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis.
Published in:
Cancer Medicine, 2023, v. 12, n. 4, p. 4259, doi. 10.1002/cam4.5294
By:
- Hatanaka, Takeshi;
- Naganuma, Atsushi;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Shimada, Noritomo
Publication type:
Article
Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib.
Published in:
Cancer Medicine, 2023, v. 12, n. 1, p. 325, doi. 10.1002/cam4.4854
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis.
Published in:
Cancer Medicine, 2022, v. 11, n. 20, p. 3796, doi. 10.1002/cam4.4763
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker.
Published in:
Cancer Medicine, 2021, v. 10, n. 11, p. 3584, doi. 10.1002/cam4.3908
By:
- Hiraoka, Atsushi;
- Kato, Masaya;
- Marui, Kaori;
- Murakami, Taisei;
- Onishi, Kei;
- Adachi, Tomoko;
- Matsuoka, Junko;
- Ueki, Hidetaro;
- Yoshino, Takeaki;
- Tsuruta, Miho;
- Aibiki, Toshihiko;
- Okudaira, Tomonari;
- Kuroda, Taira;
- Iwasaki, Ryuichiro;
- Suga, Yoshifumi;
- Miyata, Hideki;
- Ninomiya, Tomoyuki;
- Hirooka, Masashi;
- Abe, Masanori;
- Matsuura, Bunzo
Publication type:
Article
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.
Published in:
Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Tsutsui, Akemi;
- Nagano, Takuya;
- Itokawa, Norio;
- Hayama, Korenobu
Publication type:
Article
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis.
Published in:
Cancer Medicine, 2019, v. 8, n. 1, p. 137, doi. 10.1002/cam4.1909
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Kariyama, Kazuya;
- Takaguchi, Koichi;
- Atsukawa, Masanori;
- Itobayashi, Ei;
- Tsuji, Kunihiko;
- Tajiri, Kazuto;
- Hirooka, Masashi;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ishikawa, Toru;
- Ochi, Hironori;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Tsutsui, Akemi;
- Itokawa, Norio;
- Imai, Michitaka;
- Joko, Kouji
Publication type:
Article
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36052-0
By:
- Watanabe, Takao;
- Tokumoto, Yoshio;
- Joko, Kouji;
- Michitaka, Kojiro;
- Horiike, Norio;
- Tanaka, Yoshinori;
- Hiraoka, Atsushi;
- Tada, Fujimasa;
- Ochi, Hironori;
- Kisaka, Yoshiyasu;
- Nakanishi, Seiji;
- Yagi, Sen;
- Yamauchi, Kazuhiko;
- Higashino, Makoto;
- Hirooka, Kana;
- Morita, Makoto;
- Okazaki, Yuki;
- Yukimoto, Atsushi;
- Hirooka, Masashi;
- Abe, Masanori
Publication type:
Article
Hepatocellular Carcinoma Showing Tumor Shrinkage Due to an Abscopal Effect.
Published in:
Internal Medicine, 2024, v. 63, n. 2, p. 241, doi. 10.2169/internalmedicine.1844-23
By:
- Ryo Yano;
- Masashi Hirooka;
- Makoto Morita;
- Yuki Okazaki;
- Yoshiko Nakamura;
- Yusuke Imai;
- Takao Watanabe;
- Yohei Koizumi;
- Osamu Yoshida;
- Yoshio Tokumoto;
- Masanori Abe;
- Yoichi Hiasa
Publication type:
Article
Factors Related to Sleeping Disorder Due to Pruritus in Patients with Chronic Liver Disease.
Published in:
Internal Medicine, 2021, v. 60, n. 20, p. 3195, doi. 10.2169/internalmedicine.7129-21
By:
- Atsushi Hiraoka;
- Miho Onishi;
- Satsuki Koyama;
- Masaya Kato;
- Kaori Marui;
- Taisei Murakami;
- Kei Onishi;
- Tomoko Adachi;
- Junko Matsuoka;
- Hidetaro Ueki;
- Takeaki Yoshino;
- Miho Tsuruta;
- Toshihiko Aibiki;
- Tomonari Okudaira;
- Taira Kuroda;
- Ryuichiro Iwasaki;
- Yoshifumi Suga;
- Hideki Miyata;
- Tomoyuki Ninomiya;
- Masashi Hirooka
Publication type:
Article
Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis.
Published in:
Therapeutic Apheresis & Dialysis, 2017, v. 21, n. 5, p. 465, doi. 10.1111/1744-9987.12563
By:
- Toyoda, Hidenori;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Michitaka, Kojiro;
- Takaguchi, Koichi;
- Tsuji, Kunihiko;
- Itobayashi, Ei;
- Takizawa, Daichi;
- Hirooka, Masashi;
- Koizumi, Yohei;
- Ochi, Hironori;
- Joko, Koji;
- Kisaka, Yoshiyasu;
- Shimizu, Yuko;
- Tajiri, Kazuto;
- Tani, Joji;
- Taniguchi, Tatsuya;
- Toshimori, Akiko;
- Fujioka, Shinichi;
- Kumada, Takashi
Publication type:
Article
Simple Scoring System for Esophagogastric Varices Prediction in Hepatocellular Carcinoma Patients without Liver Stiffness Evaluation.
Published in:
Oncology, 2024, v. 102, n. 4, p. 291, doi. 10.1159/000533672
By:
- Hiraoka, Atsushi;
- Tada, Fujimasa;
- Ohama, Hideko;
- Fukumoto, Mai;
- Matsuoka, Kana;
- Matsuda, Takuya;
- Nakatani, Kosuke;
- Yanagihara, Emi;
- Saneto, Hironobu;
- Izumoto, Hirofumi;
- Murakami, Taisei;
- Onishi, Kei;
- Kitahata, Shogo;
- Kanemitsu-Okada, Kozue;
- Kawamura, Tomoe;
- Kuroda, Taira;
- Miyata, Hideki;
- Tsubouchi, Eiji;
- Hirooka, Masashi;
- Abe, Masanori
Publication type:
Article
Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.
Published in:
Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria.
Published in:
Oncology, 2023, v. 101, n. 9, p. 575, doi. 10.1159/000530987
By:
- Ohama, Hideko;
- Hiraoka, Atsushi;
- Tada, Fujimasa;
- Kato, Kanako;
- Fukunishi, Yoshiko;
- Yanagihara, Emi;
- Kato, Masaya;
- Saneto, Hironobu;
- Izumoto, Hirofumi;
- Ueki, Hidetaro;
- Yoshino, Takeaki;
- Kitahata, Shogo;
- Kawamura, Tomoe;
- Kuroda, Taira;
- Suga, Yoshifumi;
- Miyata, Hideki;
- Hirooka, Masashi;
- Abe, Masanori;
- Matsuura, Bunzo;
- Ninomiya, Tomoyuki
Publication type:
Article
Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.
Published in:
Oncology, 2023, v. 101, n. 9, p. 542, doi. 10.1159/000530028
By:
- Ohama, Hideko;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
Published in:
Oncology, 2023, v. 101, n. 4, p. 270, doi. 10.1159/000527676
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Kariyama, Kazuya;
- Tani, Joji;
- Hirooka, Masashi;
- Takaguchi, Koichi;
- Atsukawa, Masanori;
- Fukunishi, Shinya;
- Itobayashi, Ei;
- Tsuji, Kunihiko;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Ishikawa, Toru;
- Yasuda, Satoshi;
- Ogawa, Chikara;
- Toyoda, Hidenori;
- Hatanaka, Takeshi;
- Nishimura, Takashi;
- Kakizaki, Satoru
Publication type:
Article
Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.
Published in:
Oncology, 2022, v. 100, n. 12, p. 645, doi. 10.1159/000526521
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.
Published in:
Oncology, 2021, v. 99, n. 8, p. 518, doi. 10.1159/000515896
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Michitaka, Kojiro;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Fukunishi, Shinya;
- Ohama, Hideko;
- Kawata, Kazuhito
Publication type:
Article
Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.
Published in:
Oncology, 2020, v. 98, n. 5, p. 295, doi. 10.1159/000506293
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Fukunishi, Shinya;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Kawata, Kazuhito;
- Toyoda, Hidenori;
- Ohama, Hideko;
- Tsutsui, Akemi;
- Itokawa, Norio
Publication type:
Article
Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.
Published in:
Oncology, 2019, v. 97, n. 6, p. 334, doi. 10.1159/000502095
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Tsutsui, Akemi;
- Nagano, Takuya;
- Itokawa, Norio;
- Hayama, Korenobu
Publication type:
Article
Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.
Published in:
Oncology, 2019, v. 97, n. 5, p. 277, doi. 10.1159/000501281
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Tsutsui, Akemi;
- Nagano, Takuya;
- Itokawa, Norio;
- Hayama, Korenobu
Publication type:
Article
Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency Ablation.
Published in:
Oncology, 2019, v. 96, n. 5, p. 242, doi. 10.1159/000496225
By:
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Ochi, Hironori;
- Koizumi, Yohei;
- Izumoto, Hirofumi;
- Ueki, Hidetaro;
- Tsuruta, Miho;
- Ono, Atsushi;
- Yoshino, Takeaki;
- Aibiki, Toshihiko;
- Okudaira, Tomonari;
- Yamago, Hiroka;
- Suga, Yoshifumi;
- Iwasaki, Ryuichiro;
- Mori, Kenichiro;
- Miyata, Hideki;
- Kishida, Masato;
- Tsubouchi, Eiji;
- Abe, Masanori;
- Matsuura, Bunzo
Publication type:
Article